Recent studies have shown that CLL patients benefit from adjuvanted zoster vaccines, including individuals on chronic BTK inhibition, but that hepatitis B immunization elicited poor or no responses in both treatment-naive and BTK inhibitor treated patients [8]. The gene discussed is BTK; the disease is hepatitis A virus infection.